Arcadia Biosciences, Inc. (RKDA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.1M | -861K | -257K | -2.03M | -1.59M | -2.21M | -1.75M | -2.46M | -3.21M | -4.14M | -2.88M | -4.8M |
| Operating CF Margin % | -99.91% | -95.56% | -19.74% | -139.73% | -132.33% | -181.66% | -113.99% | -188.06% | -325.23% | -354.27% | -222.26% | -369.93% |
| Operating CF Growth % | 30.79% | 61.02% | 85.33% | 17.22% | 50.53% | 46.71% | 39.27% | 48.81% | 7.39% | -75.93% | 14.42% | -42.59% |
| Net Income | -4.38M | -1.34M | 856K | -4.46M | 2.6M | -4.06M | -1.18M | 1.06M | -947K | -452K | -639K | 818K |
| Depreciation & Amortization | 8K | 2K | 7K | 15K | 117K | 21K | 194K | 34K | 228K | 222K | 345K | 67K |
| Stock-Based Compensation | 15K | 17K | 0 | 86K | 0 | 117K | 0 | 102K | 0 | 0 | 0 | 199K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 3.65M | -170K | -1.95M | 2.98M | -3.6M | 1.34M | -525K | -3.52M | -1.89M | -2.71M | -2.21M | -4.08M |
| Working Capital Changes | -382K | 626K | 830K | -659K | -701K | 379K | -239K | -138K | -598K | -1.21M | -381K | -1.8M |
| Change in Receivables | 0 | 406K | 176K | -224K | -193K | -317K | -111K | -88K | -246K | -65K | 162K | 7K |
| Change in Inventory | 372K | 244K | 33K | -204K | -381K | -70K | 180K | 137K | 303K | -1.03M | -72K | -1.28M |
| Change in Payables | -719K | -227K | 458K | -417K | -213K | 416K | -107K | 66K | -678K | -222K | -151K | 0 |
| Cash from Investing | 0 | 0 | 0 | 250K | 500K | 2.52M | 180K | 4.64M | 0 | 52K | 5K | -4.72M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3K | -13K | 0 | 0 | -5K |
| CapEx % of Revenue | - | - | - | - | - | - | - | 0.23% | 1.32% | - | - | 0.39% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 180K | -2M | 17K | 73K | 5K | 284K |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 250K | 0 | -8K | 0 | 6.65M | -4K | 0 | 0 | -5M |
| Cash from Financing | 1.79M | 0 | 1K | 0 | 5K | 0 | 4K | 0 | 5K | 0 | 7K | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1.79M | 0 | 1K | 0 | 5K | 0 | 4K | 0 | 5K | 0 | 7K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 695K | -861K | -256K | -1.78M | -1.08M | 306K | -1.57M | 2.19M | -3.2M | -4.09M | -2.87M | -9.51M |
| Free Cash Flow | -1.1M | -861K | -257K | -2.03M | -1.59M | -2.21M | -1.75M | -2.46M | -3.22M | -4.14M | -2.88M | -4.8M |
| FCF Margin % | -99.91% | -95.56% | -19.74% | -139.73% | -132.33% | -181.66% | -113.99% | -188.28% | -326.55% | -354.27% | -222.26% | -370.32% |
| FCF Growth % | 30.79% | 61.02% | 85.33% | 17.32% | 50.73% | 46.71% | 39.27% | 48.8% | 7.01% | -74.01% | 14.42% | -42.48% |
| FCF per Share | -0.80 | -0.63 | -0.19 | -1.49 | -1.16 | -1.62 | -1.28 | -1.80 | -2.37 | -3.22 | -2.12 | -3.54 |
| FCF Conversion (FCF/Net Income) | 0.25x | 0.64x | -0.30x | 0.46x | -0.61x | 0.54x | 1.09x | -2.31x | 1.32x | 1.45x | 1.12x | -5.83x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |